Pioneering mRNA technology - Moderna
Messenger RNA (mRNA) already exists in your body. It carries a “message” - instructions that direct your cells what to do. mRNA medicines fight diseases in a different way than traditional medicine by prompting your immune system to create the tools to treat or prevent disease.
Moderna - Wikipedia
Moderna, Inc. (/ m ə ˈ d ɜːr n ə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
Our Story - Moderna
We’re making biotech history. Since 2010, we have worked to build the industry's leading mRNA technology platform. Learn more about Moderna’s history.
Moderna COVID-19 vaccine - Wikipedia
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced …
Moderna - Flagship Pioneering
2020年4月16日 · Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology, and manufacturing, with the goal of creating a new class of medicines: or as Afeyan describes it “a potential revolution in the making.”
Moderna Manufacturing: Why Norwood? – Moderna
We have produced more than 100 clinical batches in Norwood since July 2018. Having all engines under one roof has accelerated our learning.
Moderna's manufacturing operations reveal state of the company
2024年2月22日 · Eyeing its post-COVID future, Moderna has started to build out its recently acquired manufacturing facility in Marlborough, Massachusetts. The project will be used to bring the company's...
Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine
2021年9月8日 · Under the terms of the multi-year agreement, Resilience will produce mRNA for the Moderna COVID-19 vaccine at its facility in Mississauga, Ontario in Canada, for distribution worldwide.
Moderna and Thermo Fisher Scientific Announce Long-Term …
2022年2月23日 · CAMBRIDGE, Mass., and WALTHAM, Mass., February 23, 2022 – Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a 15-year strategic collaboration agreement to enable dedicated large ...
Baxter BioPharma Solutions and Moderna Announce Agreement …
2021年3月8日 · Baxter International Inc. (NYSE: BAX), a global leader in sterile medication production and delivery, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that they have entered into an agreement for Baxter BioPharma Solutions (BPS) to provide fill/finish sterile ...